2,5-DIOXOPYRROLIDIN-1-YL 3-(ACETYLTHIO)PROPANOATE, 95.0%, 1g

4-Fluorobenzoylacetonitrile>98.0%(GC)5g

Sodium 2-hydroxy-3-nitrobenzoate, 95.0%, 25g

D-(-)-Mandelic Acid>99.0%(GC)(T)500g

Sodium [3-(hexadecyloxy)propoxy]({[(4-methylbenzenesulfonyl)oxy]methyl})phosphinic acid, 95%, 1g

4-Iodo-3-nitrobenzonitrile, 95.0%, 10g

1-Chloro-3-chloromethyl-benzene, 97.0%, 25g

3-AMINO-5-CHLOROPYRIDINE-2-CARBOXYLIC ACID HCL, 95.0%, 1g

1,3-Bis[2-(4-hydroxyphenyl)-2-propyl]benzene>98.0%(GC)25g

5-{benzyl[3-(trifluoromethyl)phenyl]sulfamoyl}-2-chlorobenzoic acid, 97%, 100mg

3-acetyl-6-methoxy-1,4-dihydro-1,5-naphthyridin-4-one, 95%, 100mg

Columna HPLC NUCLEODUR® C8 Gravedad 3 µm, 150 mm, 4 mm, 1 Pieza(s)

Ethyl 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoate, 98%, 250mg